Aromatase P450 (CYP19) is an enzyme catalysing the conversion of androgens into oestrogens. We generated mice lacking aromatase activity (ArKO) by targeted disruption of Cyp19 and report the characteristic features of the ArKO ovaries and uteri as revealed by histological and biochemical analyses.
Introduction
Less than 0·1% of the follicles present at birth mature and ovulate, whereas the rest undergo atretic degeneration , McGee & Hsueh 2000 . Because atresia is a prominent feature of ovarian follicular development in mammals throughout female reproductive life (Hirshfield 1991) , the hormonal mechanisms controlling cell death have been extensively studied , Richards 1994 . These studies have demonstrated the important role of growth factors as survival factors to suppress ovarian atresia. These include epidermal growth factor/transforming growth factor , insulin-like growth factor-I, basic fibroblast growth factor and gonadotrophins (Braw & Tsafriri 1980 , Tilly et al. 1992 , Chun et al. 1994 , Eisenhauer et al. 1995 . Additionally, the ovarian steroid, oestrogen, has been shown to be an important factor in the events leading to ovulation, because oestrogen regulates ovarian follicular development by stimulating granulosa cell proliferation, increasing the formation of gap junctions between granulosa cells, and enhancing follicle-stimulating hormone-stimulated gene expression in granulosa cells, in addition to its role in the hypothalamus and pituitary gland , Richards 1994 . The importance of oestrogen in ovarian functions is further suggested by studies using hypophysectomized rats, demonstrating that treatment with oestrogen prevents decreases in ovarian weight and ovarian apoptotic DNA fragmentation induced by hypophysectomy (Billig et al. 1993) .
The main site of oestrogen synthesis, which is catalysed by an enzyme called aromatase P450 (CYP19), is in ovarian granulosa cells at reproductive ages (Yamada et al. 1993 , Shoham & Schachter 1996 . Therefore, the majority of studies have employed surgical manipulations or pharmacological administration of oestrogen agonists or antagonists to study the roles of oestrogens in the ovary. Although this approach is valid, it remains uncertain whether oestrogen synthesis is blocked definitively or the agonists/antagonists compete completely with the endogenous ligands under those experimental conditions. Thus, genetically engineered mice, which are devoid of oestrogen biosynthesis or the signalling pathways of oestrogens, provide another experimental approach to characterize and clarify the intraovarian processes dependent upon oestrogens in intact animals. Recently, mice lacking oestrogen receptor (ER : called ERKO) (Lubahn et al. 1993 , Eddy et al. 1996 , Hess et al. 1997 , Schomberg et al. 1999 , Dupont et al. 2000 , ER ( ERKO) (Krege et al. 1998 , Dupont et al. 2000 , Weihua et al. 2000 or both the receptors, ER and ( ERKO) , Dupont et al. 2000 , have been generated. Studies on these mice demonstrated the significant contributions of the oestrogen-regulated pathways in female ovarian functions as well as roles in males (Eddy et al. 1996 , Hess et al. 1997 . ERKO females are infertile and the ovaries appear hyperaemic and are blocked in follicular development at the preovulatory stage. The ERKO females are fertile but the ovaries show a partial arrest of follicular development and less frequent follicular maturation as compared with wild-type animals. We here report the generation of aromatase P450 knockout mice by targeted disruption of Cyp19 (ArKO mice), and morphological and biochemical characterization of the ovaries and uteri. The phenotype of ArKO female mice, such as infertility and anovulation, is consistent with that of ArKO mice generated independently using different targeting strategies (Fisher et al. 1998 , Honda et al. 1998 , Britt et al. 2000 . In the present study, we further report the effects of supplementation with 17 -oestradiol (E 2 ) on the reproductive organs of ArKO females.
Materials and Methods

Materials
eLONGase enzyme mix and Moloney murine leukaemia virus reverse transcriptase were purchased from Gibco-BRL (Rockville, MD, USA). ] (24 Ci/mmol) was purchased from New England Nuclear Life Science Products, Inc. (Boston, MA, USA). Human chorionic gonadotrophin (hCG), E 2 and 4-androsten-4-ol-3,17-dione were obtained from Sigma-Aldrich (Tokyo, Japan). Pregnant mare serum gonadotrophin (PMSG) was obtained from Teikoku hormone MFG Co. Ltd (Tokyo, Japan). A standard rodent chow (NMF) was obtained from Oriental Yeast (Tokyo, Japan). Oestradiol and total testosterone kits for radioimmunoassay analysis were obtained from Japan DPC Corp. (Tokyo, Japan). Spurr's epoxy resin was purchased from Polysciences, Inc. (Warrington, PA, USA). All other chemicals were of analytical grade and obtained commercially.
Animals
Animal care and experiments were carried out in accordance with institutional animal regulations. All animals were maintained on a 12 h light:12 h darkness cycle at 22-25 C and fed with standard rodent chow and water ad libitum. For comparison of phenotypes, wild-type and knockout mice from the same litters were used. To induce ovulation, female mice at 5 weeks of age were injected with PMSG (i.p., 5 IU/mouse) and then given hCG (i.p., 5 IU/mouse) 48 h later. Ovulation was determined by surgical extraction of oocyte/cumulus masses from oviducts 18 h after the second injection (Hogan et al. 1994) . To examine the effects of E 2 , ArKO females (n=7) at 4 weeks of age were given s.c. injections of E 2 dissolved in sesame oil (15 µg/25 µl per mouse per injection) every fourth day for 4 weeks. A group of ArKO mice was given s.c. injections of sesame oil alone. At 8 weeks of age, the ovaries and uteri were removed from the animals and used for analyses.
Structural analysis of Cyp19 DNA fragments containing exons of Cyp19 were amplified by polymerase chain reaction (PCR) using 0·1 µg total genomic DNA of E14-1 embryonic stem (ES) cells with eLONGase enzyme mix according to the manufacturer's instructions. Primers for amplifications were designed according to nucleotide sequence of murine CYP19 cDNA (Terashima et al. 1991) . (The sequences and locations of the primers used in this study are available on request.) Amplified fragments were confirmed by hybridization with radiolabelled primers located within the fragments and by nucleotide sequence analysis.
Generation of ArKO mice
The targeting vector was designed based on the exonintron organization of Cyp19, in which an 87 bp fragment located within exon 9, corresponding to nucleotide position +1124 to +1210 relative to the translational start site in the mature mRNA (corresponding amino acid residue number 375-402), was replaced with the neomycin-resistance gene derived from pMC1-neo (Thomas & Capecchi 1987) . The herpes-simplex virus thymidine kinase gene was inserted at the 5 end of an 8·5 kb fragment, containing exons 5, 6, 7, 8, and the 5 part of exon 9 (Fig. 1A) . The linearized target vector was electroporated into the ES cells (Takeda et al. 1996) . Two ES cell clones out of 493 independent colonies, formed in the presence of G418 and gancyclovir, were confirmed as correctly targeted. The ES cells were microinjected into C57BL/6J blastocysts to generate chimeric mice. Chimeric male mice were then mated with C57BL/6J female mice to generate mice heterozygous for the mutation, which were then intercrossed to generate mice homozygous for the Cyp19 mutation (ArKO). ArKO mice derived from the two ES cell clones showed similar phenotypes. When the offspring reached 3 weeks of age, their genotypes were determined by PCR amplification using tail genomic DNAs.
Preparation and analysis of RNA
Total RNAs were prepared from ovaries or uteri of wild-type mice, ArKO mice and E 2 -treated ArKO mice at 8 weeks of age according to the method of Mirkes (1985) . The uterine tissue samples from five animals were combined and used for RNA preparation, as the tissue of the ArKO mouse is diminished in size. For the preparation of ovarian RNA, we used five animals for both genotypes. One microgram of each RNA was used for reverse transcription with 10 pmol of an oligo dT primer in a final volume of 20 µl using Moloney murine leukaemia virus reverse transcriptase. Subsequent PCR analysis was carried out with 1 µl of the cDNA (equivalent to 0·05 µg total RNA) with a set of primers to amplify fragments containing nucleotide sequences of exons 4 and 6 or exons 8 and 9 of Cyp19 and exons 6 and 7 of Cyp17. The products were analysed by electrophoresis on 5% polyacrylamide gels. The amplified fragments were verified by nucleotide sequence analysis. Twenty micrograms of the total RNA was used for Northern blot analysis according to the method described (Sambrook et al. 1989) . A cDNA probe for lactoferrin was a generous gift from Dr C T Teng (National Institute of Environmental Heath Science, Research Triangle Park, NC, USA). cDNA probes for p53, Bax, scavenger receptor class B type I (SR-BI) and progesterone receptor were prepared by PCR amplification with a set of primers based on the nucleotide sequences (details available on request). The cDNAs obtained were verified by the nucleotide sequence analysis.
Construction of the expression vectors of murine Cyp19 and their expression in vitro
Full-length, truncated and deleted forms of Cyp19 cDNA were prepared by PCR amplification using pES-M1 as template DNA (Terashima et al. 1991) . The full-length, truncated and deleted forms of the cDNA encompass the nucleotide sequence from 4 to+1497, from 4 to +1123 and from 4 to +1497 without sequences between +1124 and +1210, relative to the translational start site, respectively. The fragments were inserted into the EcoRV site of an expression vector, pcDNA1·1/Amp (Invitrogen, Groningen, The Netherlands). Each construct together with a -galactosidase expression plasmid, pCH110, was transfected by the calcium-phosphate method into human endometrial carcinoma cells (HEC-59) (Tada et al. 1993) , which were cultured in a Dulbecco's modified Eagle's medium (pH 7·4) (DMEM) supplemented with 10% fetal bovine serum in a 35 mm dish. After incubation for 3 days, aromatase activity was measured.
Aromatase assay
A tritiated water-release assay was employed to measure aromatase activity (Lephart & Simpson 1991) . After the culture medium was changed to 1 ml DMEM without serum, the enzyme reaction was initiated by the addition of 300 pmol androst-4-ene-3,17-dione,[1 -3H(N)] with or without 10 µM 4-androsten-4-ol-3,17-dione, an aromatase inhibitor (Brodie et al. 1977) . The reaction was carried out at 37 C for 4 h. When the activity in the ovaries was measured, two females at 10-12 weeks of age were used for each measurement. Whole ovarian dispersates in 1 ml DMEM in a 35 mm dish were prepared mechanically using fine forceps and incubated with the tritiated substrate as above. Aromatase activity was expressed as fmol [ 3 H]water released/dish per -galactosidase activity per h (means ... of data derived from four independent experiments) for the in vitro expressed enzyme and fmol [ 3 H]water released per mg wet weight per h (means ... of data derived from seven independent experiments) for the ovarian activity.
Analysis of serum steroids
Blood was collected by cardiac puncture from anaesthetized animals. Serum samples from three to four mice of each genotype at 16-20 weeks of age were mixed. Of the serum mixture, 0·5 ml and 0·3 ml were used for the determination of E 2 and testosterone concentrations respectively, using radioimmunoassay kits according to the manufacturer's instructions. The measurements were done at least three times using serum samples collected from different groups of animals.
Histological examination
Five ArKO and wild-type females at 8 weeks of age or 8 months of age were used for histological study. ArKO mice treated with E 2 or vehicle alone were also subjected to histology. Ovaries and uteri removed from mice were fixed in a solution of 10% buffered formalin for 24 h, dehydrated and embedded in paraffin. Sections were cut 3 µm thick and stained with haematoxylin-eosin. For electron microscopy, the tissues were cut into small pieces, immersed in a fixative containing 2% paraformaldehyde and 2% glutaraldehyde in 0·1 M cacodylate buffer (pH 7·2) for 1 h at 4 C followed by postfixation in 1% osmic acid in 0·1 M cacodylate buffer (pH 7·2) for 1 h at 4 C. After fixation, the tissues were rinsed, dehydrated in graded ethyl alcohol and embedded in a Spurr's epoxy resin. Ultra-thin sections were doubly contrasted with uranyl acetic acid and lead citric acid, and observed with a Hitachi H-700H electron microscope.
Statistical analysis
Data were analysed by Wilcoxon rank-sum test, Wilcox signed rank test or chi-square test. The difference was regarded to be significant when P<0·05. Figure 1A shows the exon-intron organization of Cyp19. According to the gene structure, we constructed a targeting vector in which an 87 bp protein coding sequence in exon 9 was replaced with the neomycin-resistance gene. Southern blot analysis demonstrated that Probe A located in intron 9 hybridized with 4·8 kb and 2·7 kb BamHI fragments derived from the wild-type and the mutated alleles respectively (Fig. 1B) . Furthermore, PCR amplification of the wild-type genomic DNA using a set of primers respectively located in exons 8 and 9 yielded a 5·5 kb fragment, whereas the amplification of genomic DNA from mice heterozygous for the mutation generated a 6·5 kb fragment in addition to the 5·5 kb fragment. Both fragments positively hybridized with Probe A, while only the 6·5 kb fragment was detected with the probe, Probe N, located in the neomycin-resistance gene (Fig. 1C) . Thus, the conditions of the PCR amplification allowed us to determine the genotype of offspring (Fig. 1D) .
Results
Generation of ArKO mice
Expression of aromatase P450 in the ovaries
Expression of Cyp19 was analysed with RT-PCR using RNAs prepared from wild-type and ArKO ovaries. As shown in Fig. 2A , transcripts encompassing nucleotide sequence of exon 4 to exon 6 of Cyp19 were detected in the cDNAs of the wild-type and ArKO ovaries, but those containing the sequence from exon 8 to exon 9 were detected only in the cDNAs of the wild-type ovaries. As a control amplification, comparable amounts of transcripts of Cyp17 were detected in the ovaries of both genotypes.
Thus, these results established that transcripts with a full-length sequence were absent in ArKO mice. In order to ensure that the disruption of the gene resulted in a loss of the enzyme activity, we constructed expression vectors containing nucleotide sequences coding for full-length, truncated and deleted forms of CYP19 and measured the aromatase activity of the products expressed in cultured cells using the tritiated-water releasing method. As shown in Fig. 2B , the construct containing the full-length sequence expresses the functionally active enzyme, whereas neither the truncated nor deleted sequence in the expression vector generated products with aromatase activity. We measured the activity in the ovaries as shown in Fig. 2C . The aromatase activity in the ovaries of wild-type females was 16·1 5·0 fmol/mg wet weight per h, whereas it was greatly reduced in the presence of aromatase inhibitor (1·42 0·74 fmol/mg wet weight per h). In the ArKO ovaries, we detected only negligible levels of the activity (1·07 0·24 fmol/mg wet weight per h).
Serum steroid levels
The concentrations of steroids in serum are presented in Table 1 . The concentrations of E 2 and testosterone in the wild-type females were 23·7 pg/ml and 132 pg/ml respectively. The concentration of testosterone in the wild-type male mice was 2630 pg/ml. The levels of testosterone were markedly elevated in the ArKO mice, especially in the ArKO females, where they were approximately tenfold higher than in the wild-type females (P<0·0001). As expected, the levels of E 2 in the ArKO mice were below the limit of detection in both females and males (n=4, detection limit >10 pg/ml).
Fertility of ArKO females
We observed that mice homozygous for the mutation were born with an expected ratio of the Mendelian frequency when the heterozygous mice were crossed. Continuous test mating revealed that ArKO females were totally infertile (tested by ten mates), while wild-type and heterozygous females were productive with similar frequencies and average litter sizes.
Morphological and histological analysis of the female reproductive organs of ArKO mice
Gross morphology of the reproductive organs at 8 weeks of age is shown in Fig. 3A and B. The uterine size of the mutant animal was markedly reduced (Fig. 3B) as compared with that of wild-type females (Fig. 3A) . The wet weights of wild-type and ArKO uteri were 97·8 53·5 mg and 14·5 1·98 mg respectively (Fig. 4A) . However, gross alteration in morphology of the organ was not apparent at this age. Histology of the ArKO ovaries demonstrated the presence of follicles at various maturational stages including primary to large antral follicles (Fig. 3F) . Nevertheless, we observed no corpus luteum in the ArKO ovaries, indicating anovulation. The defect in ovulation of ArKO females was further examined by an experiment to induce superovulation using mice at 5 weeks of age. Treatment with PMSG followed by injection of hCG induced ovulation in wild-type females, but not in ArKO females (data not shown). In accordance with anovulation, we observed fewer numbers of luteinized interstitial cells in the ArKO ovaries (Fig. 3G) , which were markedly different from the wild-type ovaries, where corpora lutea were present (Fig. 3D ) and the interstitial cells filled the intraovarian space (Fig. 3E) .
Histology of the ArKO uterus demonstrated a decrease in endometrial and myometrial thickness (Fig. 4B) . Ultramicroscopy revealed numerous lipid droplets and spherical mitochondria with tubular cristae and the high electron-dense matrix in the wild-type luteinized interstitial cells (Fig. 5A and B) . In addition, little smooth endoplasmic reticulum was observed. In contrast, smooth endoplasmic reticulum that consisted of closely packed, branching and anastomosing tubules with similar diameters occupied most of the cytoplasm of the ArKO luteinized interstitial cells (Fig. 5C and D) . Furthermore, lipid droplets and rough endoplasmic reticula were rarely observed in the ArKO cells.
The gross anatomy of the reproductive organs of ArKO females at 8 months of age is presented in Fig. 3C . As in young animals, the uterine size was diminished. Furthermore, haemorrhagic formation in the ovaries was observed in the aged ArKO mice. Histological examination of the ArKO ovaries showed depletion of the follicles, formation of large haemorrhages (Fig. 3J ) and the sporadic presence of macrophage-like cells in the follicular antrum (Fig. 3K) . In addition, we observed mast cells in ArKO ovaries much more frequently than in the wild-type ovaries (data not shown).
Alternations in gene expression in the ovaries and uteri of ArKO mice
Because ArKO females are defective in ovulation, the ovarian follicles undergo atretic degeneration. As apoptosis seems to be one of the underlying mechanism for the process, we examined expression levels of the p53 and Bax genes in ArKO ovaries by Northern blot analysis. As shown in Fig. 6A , the levels of the p53 and Bax genes in ArKO ovaries were elevated as compared with those in the wild-type ovaries (3·3 0·12-fold for p53 and 1·8 0·2-fold for Bax over the wild-type levels respectively). In contrast, comparable levels of SR-BI expression were observed in the wild-type and ArKO ovaries (0·89 0·2-fold over the wild-type levels). When we examined uterine expression levels of the lactoferrin and progesterone receptor genes, which are well documented to be transcribed under the regulation of oestrogen, the levels in ArKO mice were found to be much lower than those in wild-type mice (Fig. 6B) . These results further support a loss of the function of Cyp19 in ArKO mice.
Effects of E 2 supplementation on ovaries and uteri of ArKO mice
When ArKO females at 4 weeks of age were supplemented with E 2 every fourth day for 4 weeks, greater numbers of ovarian follicles were evident in the treated ovaries compared with those of age-matched untreated ArKO mice (Fig. 3H ) Furthermore, we observed many luteinized interstitial cells in the intraovarian space (Fig. 3I) . Nevertheless, we did not detect a typical corpus luteum in the E 2 -treated ovaries. These results indicate that E 2 might be able to support development of ovarian follicles, but is not sufficient to promote ovulation of the follicles. Electron microscopy demonstrated that the E 2 supplementation reverses the unusual accumulation of smooth endoplasmic reticulum in the luteinized interstitial cells of ArKO ovaries (Fig. 5E and F) . Furthermore, we observed lipid droplets in the cytosol of the interstitial cells and mitochondria with structures showing characteristics of steroid-producing cells. Although E 2 supplementation supported development of ovarian follicles, the treatment did not affect the expression levels of p53 (3·5 0·2-fold) and Bax (1·5 0·1-fold) mRNAs at all in the ArKO ovaries as analysed by Northern blot analysis (Fig. 6A) .
When ArKO mice received E 2 , the uterine size of ArKO mice, which was approximately 15% of the size of the wild-type uteri, was markedly increased (89·2 19·4 mg), reaching levels of wild-type females (97·8 53·5 mg) (Fig. 4A) . Histological analysis confirmed the proliferation of cells in the endometrium as well as in the myometrium (Fig. 4B) . Northern blot analysis also revealed marked enhancement of the lactoferrin and progesterone receptor gene expression, 2·7-fold and 1·3-fold over the levels of the wild-type mice respectively Figure 2 Functional disruption of Cyp19. (A) Expression of Cyp19 in the ovaries. Total RNAs prepared from the wild-type (+/+) or ArKO ( / ) ovaries were reverse transcribed. A portion of the cDNAs was used for PCR amplification of fragments encompassing exon (Ex) 4 to 6 (380 bp) or exon 8 to 9 (284 bp) of Cyp19, and exon 6 to 7 (319 bp) of Cyp17. (B) Aromatase activity expressed in vitro. The activity was assayed by the tritiated water-releasing method. The cells were transfected with an expression vector containing a full-length form (full-length), a truncated form (truncated form) or a deleted form (deleted form) of the Cyp19 cDNA, or the expression vector alone (vector alone). After incubation for 3 days, androst-4-ene-3,17-dione,[1 -3H(N)] was added and cells were incubated at 37 C for 4 h in the absence (open bars) or presence (solid bars) of the aromatase inhibitor, 10 M 4-androsten-4-ol-3,17-dione, in serum-free DMEM. The radioactivity released from the substrate into the medium as a form of H 2 O was determined. The activity is expressed as fmol tritiated water released/ -galactosidase activity/h. Each bar represents the mean S.E.M. of four experiments. The endogenous tritiated water-releasing activity of the host cells is 18·7 4·2 fmol/h per dish and 20·8 1·1 fmol/h per dish in the absence and presence of 10 M 4-androsten-4-ol-3,17-dione respectively. (C) Aromatase activity in the wild-type and the ArKO ovaries. Whole ovarian dispersates from each genotype in serum-free DMEM were incubated with the radioactive substrate in the absence (open bars) or presence (solid bars) of 10 M 4-androsten-4-ol-3,17-dione to measure tritiated water-releasing activity. The activity was expressed as fmol tritiated water released/mg wet weight/h. Each bar represents the mean S.E.M. of seven experiments. Table 1 Concentrations of E 2 and testosterone in serum. Four pools of serum from three to four mice at 16-20 weeks of age were used to determine their means ( S.E.M.). The limit for detection of E 2 was 10 pg/ml under the present experimental conditions E 2 (pg/ml) Testosterone (pg/ml) (Fig. 6B) . These results indicated that the oestrogen signalling pathway is functional, at least, in the uteri of ArKO mice.
Discussion
In the present study, we generated aromatase knockout mice in order to assess the roles of oestrogen in the ovary. Targeted disruption of Cyp19 was confirmed by RT-PCR analysis, which demonstrated the absence of full-length transcripts of Cyp19 in the ovaries and also in other tissue sites examined, including testes and brains (data not shown). Furthermore, the aromatase activity in the ovaries of ArKO mice was greatly reduced. The in vitro expression study provided evidence that deletion of the nucleotide sequence between +1124 and +1210 relative to the translational start site, which was the region to be replaced with the neomycin-resistance gene in the present knockout strategy, resulted in a complete loss of the aromatase activity. The replaced nucleotide sequence encodes one of the highly conserved regions of the CYP19 protein, which is referred to as the I-helix and believed to form the substrate-binding pocket proximal to the heme prosthetic group (Graham-Lorence et al. 1991) . Therefore, the complete inactivation of enzyme activity by the replacement appears to be highly plausible. Nevertheless, we were unable to exclude completely the possibility that some other unidentified gene product with aromatase activity is present, as suggested by the study on the ERKO mice ), because we observed very low tritiated water-releasing activity in the ArKO ovaries. However, the activity appears to be unable to generate sufficient quantities of oestrogens to exert physiological effects in the mice, because ArKO females are infertile and their uteri are markedly diminished in size. We also observed that hepatic expression of fatty acidmetabolizing enzymes was severely impaired in ArKO males (Nemoto et al. 2000) .
The formation of haemorrhagic cysts on the surface of ovaries is one of the characteristic features of aged ArKO females. We occasionally observed macrophage-like cells in the follicular antrum of the ArKO ovaries, where they appear to act as phagocytes to remove superfluous cells. In contrast, invasion of macrophages into the follicular antrum of the wild-type ovaries was seldom observed under microscopic examinations. Thus, it was suggested that under specific physiological conditions such as absence of oestrogens (or excess of androgens), macrophages might invade into the follicular antrum, phagocytose and produce an empty space in the follicle, into which blood flows and accumulates, consequently leading to the formation of a haemorrhagic cystic follicle.
When ArKO mice were supplemented with E 2 by subcutaneous injections, the wet weight of the uteri and the uterine expression of oestrogen-regulated genes, such as the lactoferrin and progesterone receptor genes, was markedly increased. However, neither anovulation nor the elevated level of expression of the pro-apoptotic genes in the ovaries of ArKO mice were ameliorated by the treatment. It is apparent that redundant endocrine/ paracrine/autocrine control mechanisms are involved in the regulation of ovarian functions in a combinatorial manner ). Thus, experimental protocols which mimic the physiological hormonal milieu similar to those occurring in the wild-type female mice might be necessary to reverse the ovarian dysfunction of ArKO females.
As ArKO ovaries are defective in ovulation, all ovarian follicles of the mutant animals appear to undergo atretic degeneration. Apoptosis appears to be a process associated with follicular atresia , McGee & Hsueh 2000 . We observed apoptotic DNA fragmentation (data not shown) and expressions of pro-apoptotic genes such as p53 (Burns & El-Deiry 1999 , Tilly et al. 1995b and Bax (Oltvai et al. 1993 , Tilly et al. 1995a , Perez et al. 1999 with elevated levels in the ArKO ovaries compared with those seen in the wild-type ovaries. Thus, apoptotic cell death might be stimulated in the ArKO ovaries, this contributes to the occurrence of depletion of ovarian follicles at a relatively early stage of life in ArKO females when compared with the wild-type females.
ERKO female mice showed failure of the normal maturational events leading to successful ovulation and luteinization . It was also reported that ERKO females form large haemorrhagic cysts in the ovaries (Schomberg et al. 1999) . Thus, these results, together with those of the present study, indicate that anovulation, defects in luteinization and haemorrhage formation might be due to defects in oestrogen actions mediated by ER . 
